Literature DB >> 2950774

Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit.

P Gluszko, B Rucinski, J Musial, R K Wenger, A H Schmaier, R W Colman, L H Edmunds, S Niewiarowski.   

Abstract

The role of platelet fibrinogen receptors and platelet-protein interaction in platelet consumption during simulated cardiopulmonary bypass was investigated. In five recirculation experiments, with whole blood, the platelet count fell to 13% of initial values and in two experiments, with blood from patients with Bernard-Soulier syndrome, to 3% of normal values. However, in three experiments with blood from the patients with Glanzmann's thrombasthenia, the platelet count decreased to 69% of initial values. The extent of platelet consumption in normal blood was diminished to only 72% by addition of 0.5 microM prostaglandin E1 (PGE1) (5 experiments) and to 80% by precoating surfaces of the circuit with 2.5% human albumin (5 experiments). beta-Thromboglobulin antigen (beta TG) loss from platelets was associated with thrombocytopenia. The extent of beta TG loss was significantly reduced by the addition of PGE1 to blood or precoating surfaces with albumin. Proteins adsorbed on the surface of the circuit exposed to normal blood were removed with 0.5% Triton X-100. Some of these proteins were identified to be glycoprotein IIIa (GPIIIa) (3.4-4.3 micrograms/ml), beta TG (1.0-1.6 micrograms/ml), and fibrinogen (1.9-3.7 micrograms/ml). The amount of GPIIIa recovered in the Triton X-100 eluates correlated with the number of platelets lost during recirculation. These studies indicate that exposure of fibrinogen receptors associated with GPIIb-GPIIIa complex contributes to platelet consumption during cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950774     DOI: 10.1152/ajpheart.1987.252.3.H615

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

Review 1.  Is prosthetic valve thrombogenicity related to design or material?

Authors:  L H Edmunds
Journal:  Tex Heart Inst J       Date:  1996

2.  Effect of Gabexate mesilate on postoperative blood loss in cardiovascular surgery using cardiopulmonary bypass.

Authors:  A Kohyama; R Goh; K Mori; S Yasumoto; H Kimura; H Kitahata
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

3.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

Authors:  C S Rinder; H M Rinder; B R Smith; J C Fitch; M J Smith; J B Tracey; L A Matis; S P Squinto; S A Rollins
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 4.  Natural and synthetic antifibrinolytics in cardiac surgery.

Authors:  J F Hardy; J Desroches
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.